This website uses cookies, with the aim of ensuring that you have the best possible online experience. In using our website, you are giving your consent to the terms and conditions of our privacy policy. privacy policy.
closeNotre gestionnaire de fonds et spécialiste actions, Cyrill Plüss, est interviewé par allnews. Il parle du développement fulgurant dans l’édition du génome.
